Molecular Psychiatry - Table of Contents alert Volume 18 Issue 3

TABLE OF CONTENTS Volume 18, Issue 3 (March 2013) In this issue Image Letters to the Editor Expert Reviews Immediate Communication Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Discover the benefits of publishing with Molecular Psychiatry: the Open Access option Molecular Psychiatry, the #1 journal in psychiatry, offers authors the option to publish their articles with immediate open access and exposure upon publication. Visit the Author Page for more details on open access and the benefits of publishing with Molecular Psychiatry!   Image Top Disinhibition goes up in smoke F Marti, U Maskos and P Faure Mol Psychiatry 2013 18: 267; 10.1038/mp.2013.14 Full Text Letters to the Editor Top Glutamate normalization with ECT treatment response in major depression J Zhang, K L Narr, R P Woods, O R Phillips, J R Alger and R T Espinoza Mol Psychiatry 2013 18: 268-270; advance online publication, May 8, 2012; 10.1038/mp.2012.46 Full Text Role of folate receptor autoantibodies in infantile autism V T Ramaekers, E V Quadros and J M Sequeira Mol Psychiatry 2013 18: 270-271; advance online publication, April 10, 2012; 10.1038/mp.2012.22 Full Text Converging evidence for central 5-HT effects in acute tryptophan depletion? G van der Plasse Mol Psychiatry 2013 18: 271-272; advance online publication, May 1, 2012; 10.1038/mp.2012.44 Full Text Expert Reviews Top Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function J C Stingl, J Brockmöller and R Viviani Mol Psychiatry 2013 18: 273-287; advance online publication, May 8, 2012; 10.1038/mp.2012.42 Abstract | Full Text A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology R Bogdan, L W Hyde and A R Hariri Mol Psychiatry 2013 18: 288-299; advance online publication, May 22, 2012; 10.1038/mp.2012.35 Abstract | Full Text Immediate Communication Top Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for neuroprotection Open Y Koutmani, P K Politis, M Elkouris, G Agrogiannis, M Kemerli, E Patsouris, E Remboutsika and K P Karalis Mol Psychiatry 2013 18: 300-307; advance online publication, February 5, 2013; 10.1038/mp.2012.198 Abstract | Full Text Original Articles Top Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety K S Sink, D L Walker, S M Freeman, E I Flandreau, K J Ressler and M Davis Mol Psychiatry 2013 18: 308-319; advance online publication, January 31, 2012; 10.1038/mp.2011.188 Abstract | Full Text Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation V L Batalha, J M Pego, B M Fontinha, A R Costenla, J S Valadas, Y Baqi, H Radjainia, C E Müller, A M Sebastião and L V Lopes Mol Psychiatry 2013 18: 320-331; advance online publication, February 28, 2012; 10.1038/mp.2012.8 Abstract | Full Text Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study G I Papakostas, R C Shelton, G Kinrys, M E Henry, B R Bakow, S H Lipkin, B Pi, L Thurmond and J A Bilello Mol Psychiatry 2011 18: 332-339; advance online publication, December 13, 2011; 10.1038/mp.2011.166 Abstract | Full Text Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants E R Gamazon, J A Badner, L Cheng, C Zhang, D Zhang, N J Cox, E S Gershon, J R Kelsoe, T A Greenwood, C M Nievergelt, C Chen, R McKinney, P D Shilling, N J Schork, E N Smith, C S Bloss, J I Nurnberger, H J Edenberg, T Foroud, D L Koller, W A Scheftner, W Coryell, J Rice, W B Lawson, E A Nwulia, M Hipolito, W Byerley, F J McMahon, T G Schulze, W H Berrettini, J B Potash, P P Zandi, P B Mahon, M G McInnis, S Zöllner, P Zhang, D W Craig, S Szelinger, T B Barrett and C Liu Mol Psychiatry 2013 18: 340-346; advance online publication, January 3, 2012; 10.1038/mp.2011.174 Abstract | Full Text Antipsychotics activate the TGFβ pathway effector SMAD3 T Cohen, S Sundaresh and F Levine Mol Psychiatry 2013 18: 347-357; advance online publication, January 31, 2012; 10.1038/mp.2011.186 Abstract | Full Text Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice A C Santuccione, M Merlini, A Shetty, C Tackenberg, J Bali, M T Ferretti, J McAfoose, L Kulic, C Bernreuther, T Welt, J Grimm, M Glatzel, L Rajendran, C Hock and R M Nitsch Mol Psychiatry 2013 18: 358-368; advance online publication, June 12, 2012; 10.1038/mp.2012.70 Abstract | Full Text Cerebral folate receptor autoantibodies in autism spectrum disorder Open R E Frye, J M Sequeira, E V Quadros, S J James and D A Rossignol Mol Psychiatry 2013 18: 369-381; advance online publication, January 10, 2012; 10.1038/mp.2011.175 Abstract | Full Text Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement S Tolu, R Eddine, F Marti, V David, M Graupner, S Pons, M Baudonnat, M Husson, M Besson, C Reperant, J Zemdegs, C Pagès, Y A H Hay, B Lambolez, J Caboche, B Gutkin, A M Gardier, J-P Changeux, P Faure and U Maskos Mol Psychiatry 2013 18: 382-393; advance online publication, July 3, 2012; 10.1038/mp.2012.83 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Molecular Psychiatry. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.